Mansilla-Polo Miguel (Miguel Mansilla-Polo)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Top Venues

Rheumatology advances in practice

Clinical and experimental dermatology

International journal of dermatology

The American Journal of dermatopathology

This page only lists publications with an associated author ORCID identifier.

Publications

Mansilla-Polo Miguel, Begoña Escutia-Muñoz, Margarita Llavador-Ros, Rafael Botella-Estrada
Identification of c.104T > G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study. Clinical and experimental dermatology (2023)
Carlos Abril-Pérez, Mansilla-Polo Miguel, Daniel Martin-Torregrosa, Rafael Botella-Estrada
Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment. Clinical and experimental dermatology (2023)
Mansilla-Polo Miguel, Begoña Escutia-Muñoz, Daniel Martín-Torregrosa, Carlos Abril-Pérez, Vicent Martínez-Cózar, Rafael Botella-Estrada
Single Digital Metastasis of Rectal Adenocarcinoma. The American Journal of dermatopathology 45 (10) (2023)
Mansilla-Polo Miguel, Carlos Abril-Pérez, Daniel Martín-Torregrosa, Javier López-Davia, Blanca de Unamuno-Bustos, Ignacio Torres-Navarro, Begoña Escutia-Muñoz, Rafael Botella-Estrada
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice. The Australasian journal of dermatology (2023)
Mansilla-Polo Miguel, Begoña Escutia-Muñoz, Vicent Martínez-Cozar, Rafael Botella-Estrada
Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report. International journal of dermatology (2023)
Mansilla-Polo Miguel, Miguel Á Navarro-Mira, Rafael Botella-Estrada
Hemihypoatrophy as an extraordinary manifestation of linear morphoea. Rheumatology advances in practice 6 (3) (2022)
Mansilla-Polo Miguel, Miguel Á Navarro-Mira, Rafael Botella-Estrada
Hemihypoatrophy as an extraordinary manifestation of linear morphoea. Rheumatology advances in practice 6 (3) (2022)